Status:
COMPLETED
Quality of Life in Patients With Congenital Afibrinogenemia
Lead Sponsor:
University Hospital, Geneva
Conditions:
Afibrinogenemia, Congenital
Eligibility:
All Genders
8+ years
Brief Summary
The aim of this observational study is to evaluate the quality of life in patients with congenital afibrinogenemia using the Haemo-QoL SF for kids and the Haem-A-QoL for adult patients.
Detailed Description
In this observational study, children and adults suffering from congenital afibrinogenemia confirmed by biology will be enrolled. All patients will receive a questionnaire on quality of life in their ...
Eligibility Criteria
Inclusion
- Congenital afibrinogenemia confirmed by biology (absence of circulating fibrinogen) and genotype
Exclusion
- Lack of participant's consent
- Patient unable to understand the questionnaire
Key Trial Info
Start Date :
June 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03484065
Start Date
June 1 2016
End Date
June 1 2020
Last Update
November 12 2020
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Orange Count
Orange, California, United States, 92868
2
Cohen Children's Medical Center
New Hyde Park, New York, United States, 11040
3
Béni Messous
Algiers, Algeria
4
University of Calgary
Calgary, Canada